LYMPHOGENiX
Covent Garden
About LYMPHOGENiX
LYMPHOGENiX aspires to be a global leader in lymphatic science, addressing unmet needs in both human and animal health. Our purpose is to unleash the lymphatic system's latent potential to tackle real-world health concerns.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $339.6K
- Funding stage: Seed
- Last round: Pre-Seed (Jul 2025)
- Website: lymphogenix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/lymphogenix-73512 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.